Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.3 - Volex plc
-
Alliance Witan PLC - Net Asset Value
-
EfTEN United Property Fund invests 2.5 million euros in the EfTEN Real Estate Fund 5
-
Squash The Beef: Habit Burger & Grill Hosts Reconciliation Burger Bash for In-N-Out Burger Fans
-
AYR Launches Later Days Fruit-Flavored Vape Collection
-
Electra Secures 10-Year Permit to Advance Exploration for Idaho Copper and Cobalt Properties
-
Cibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed Rape
-
ZenaTech to Execute Series of Acquisitions to Launch Drone-as-a-Service
-
Squash The Beef: Habit Burger & Grill Hosts Reconciliation Burger Bash for In-N-Out Burger Fans
-
Intermap Awarded Initial U.S. Department of Defense Subcontract for Irregular Warfare Technical Support Directorate
-
Brixton Metals Drills 3.00m of 5.67 g/t Gold within 48.50m of 1.16 g/t Gold at its Trapper Gold Target
-
Scorpius Holdings Launches Scorpius Ventures to Support U.S. Biotech Innovation through Flexible Equity-Based Onshoring Model
-
Thumzup to Use Bitcoin for Payments to Gig Economy Workers
-
Four Inc. and HAProxy Technologies Partnership Helps Public Sector Slash Technology Costs
-
Universal Security Instruments Reports Second-Quarter Results
-
Survey shows Canadian nostalgia toward bread is on the “rise”
-
Alterity Therapeutics Appoints Abby Macnish Niven as Company Secretary
-
MILKBAG & bera.buzz – Your Gateway to Cult Memecoins with Real Utility
-
Calvient Unveils Practice Intelligence to Revolutionize Operational Efficiency in Healthcare Practices
-
AVTL filed draft red herring prospectus with Securities and Exchange Board of India
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
ShorePoint Earns the Tech100 Distinction for Fifth Consecutive Year
-
Panavance Announces New Discovery that Misetionamide Directly Inhibits Oncogenic Transcription Factor c-MYC
-
Ocugen Announces Compelling Preliminary Data for OCU410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
-
Troilus Progresses Project Financing with Two Additional LOIs for up to Another US$500 Million from Scandanavian Export Credit Agencies Finnvera (Finland) and EKN (Sweden)
-
GDS Holdings Limited Reports Third Quarter 2024 Results
-
Aya Gold & Silver Reports Zgounder At-Depth High-Grade Drill Results
-
NextGen Digital Completes Cloud AI Hosting and PCSections.com Platform Developments and Publishes Second Quarter Financial Results
-
Fireweed Metals Wins Robert E. Leckie Award for Responsible and Innovative Exploration and Mining Practices
-
2024 ClimateTech In Focus Report Launched at COP29
-
Green Shift Completes Final Payment under Armstrong Option Agreement
-
Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card Now for Desperately Needed Change to the AIM Board
-
Apeiron Enrolls First Patient in Phase 1a/b Study of PRMT5 Inhibitor GTA182 for MTAP-Deleted Solid Tumors
-
Capital City Bank Named Among “Best Banks to Work For” By American Banker For 12 Consecutive Years
-
PropW Concludes WOW SUMMIT Thailand Tour, Strengthening Ties with Crypto Community Amid Market Growth
-
Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
-
Aduro Clean Technologies Engages Global Leader Zeton for Design and Fabrication of Hydrochemolytic™ Pilot Plant
-
J-Long Group Limited Announces Receipt of NASDAQ Determination Letter
-
Truepic Awarded Fast Company’s 2024 Next Big Things in Tech
-
White Gold Corp. Announces Significant Increase in Mineral Resources to 1,203,000 oz Gold Indicated and 1,116,600 oz Gold Inferred at the White Gold Project, Yukon, Canada
-
Doge Jones Industrial Average (DJI) Launches Memecoin Sentiment Tracker, As Memecoin Supercycle Accelerates
-
Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market
-
Oral Presentation at AASLD The Liver Meeting® 2024 Highlights Broad Clinical Activity of Chemomab’s CM-101 Across Multiple Biomarkers and Its Disease-Modifying Potential in Primary Sclerosing Chola
-
PyroGenesis Signs Initial Energy Transition Contract with One of the Largest Multinational Steel Manufacturers
-
OTC Markets Group Welcomes SWEDENCARE AB to OTCQX
-
Spineart Celebrates 100,000 Ti-Life Technology Cages Sold Worldwide
-
FIRE Funds Launch First Suite of ETFs Tailored to the Financial Independence, Retire Early (FIRE) Community
-
UCLOUDLINK GROUP INC. to Report Third Quarter 2024 Financial Results on November 26, 2024
-
Hyperscale Data Declares Monthly Cash Dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock
-
Updates on Graphex China Expansion Plan


